Stock listing
3371 Stock Price, News, Filings & Events — Corbus Pharmaceuticals Holdings, Inc.
Selected listing: 3371 · GETTEX · EUR · DE
This page tracks Corbus Pharmaceuticals Holdings, Inc.'s 3371:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 3371:GETTEX. 3371:GETTEX is the stock-level entry point for investors researching Corbus Pharmaceuticals Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Corbus Pharmaceuticals Holdings, Inc. (Ticker: CRBP) is a public company based in the United States, with a market capitalization of approximately $166.9 million. The company focuses on developing innovative therapies for rare and serious diseases. Corbus is committed to advancing its clinical programs and expanding its portfolio to address unmet medical needs.
- Ticker
- 3371:GETTEX
- Asset type
- Stock
- Market cap
- $157.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Corbus Pharmaceuticals Holdings, Inc. 3371:GETTEX stock context
This page tracks Corbus Pharmaceuticals Holdings, Inc.'s 3371:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 3371:GETTEX. 3371:GETTEX is the stock-level entry point for investors researching Corbus Pharmaceuticals Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Corbus Pharmaceuticals Holdings, Inc. (Ticker: CRBP) is a public company based in the United States, with a market capitalization of approximately $166.9 million. The company focuses on developing innovative therapies for rare and serious diseases. Corbus is committed to advancing its clinical programs and expanding its portfolio to address unmet medical needs.
Latest news from Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
September 14, 2026
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
September 11, 2026
Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 17, 2026
Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
August 4, 2026
Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer
July 28, 2026
Corbus Pharmaceuticals Holdings, Inc. earnings calls
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q3 2020 Earnings Call
November 10, 2020 · Replay with transcript and chapters
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q2 2020 Earnings Call
August 6, 2020 · Replay with transcript and chapters
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q1 2020 Earnings Call
May 11, 2020 · Replay with transcript and chapters
Research Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc. investor report
Review AI stock analysis and investor report context for 3371:GETTEX.
Corbus Pharmaceuticals Holdings, Inc. company profile
View the public company page for Corbus Pharmaceuticals Holdings, Inc. on 6ix.
Corbus Pharmaceuticals Holdings, Inc. news
Read company news and market updates connected to Corbus Pharmaceuticals Holdings, Inc..
Corbus Pharmaceuticals Holdings, Inc. investor events
Find investor webinars, events, and replay context for Corbus Pharmaceuticals Holdings, Inc..
Alternate listings
CRBP:NASDAQ
US · USD
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
A3D54P:LS
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
A3D54P:LSX
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
CRBP:BOATS
US · USD
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
0SZI:LSE
GB · USD
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
3371:TRADEGATE
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
3371:DUS
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
3371:FWB
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
3371:HAM
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
3371:MUN
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.
3371:SWB
DE · EUR
Alternate listing for Corbus Pharmaceuticals Holdings, Inc.; the primary context on this page is 3371:GETTEX.